» Articles » PMID: 33099579

Optical Coherence Tomography Angiography in Diabetic Retinopathy: an Updated Review

Overview
Journal Eye (Lond)
Specialty Ophthalmology
Date 2020 Oct 25
PMID 33099579
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus. Optical coherence tomography angiography (OCTA) has been developed to visualize the retinal microvasculature and choriocapillaris based on the motion contrast of circulating blood cells. Depth-resolved ability and non-invasive nature of OCTA allow for repeated examinations and visualization of microvasculature at the retinal capillary plexuses and choriocapillaris. OCTA enables quantification of microvascular alterations in the retinal capillary network, in addition to the detection of classical features associated with DR, including microaneurysms, intraretinal microvascular abnormalities, and neovascularization. OCTA has a promising role as an objective tool for quantifying extent of microvascular damage and identify eyes with diabetic macular ischaemia contributed to visual loss. Furthermore, OCTA can identify preclinical microvascular abnormalities preceding the onset of clinically detectable DR. In this review, we focused on the applications of OCTA derived quantitative metrics that are relevant to early detection, staging and progression of DR. Advancement of OCTA technology in clinical research will ultimately lead to enhancement of individualised management of DR and prevention of visual impairment in patients with diabetes.

Citing Articles

Flow and ischemic changes in retina and choroid across diabetic retinopathy spectrum: a SS-OCTA study.

Yang Q, Teo K, Hong Y, Tan B, Schmetterer L, Cheung C Eye (Lond). 2025; .

PMID: 40016519 DOI: 10.1038/s41433-025-03639-y.


Comparative analysis of retinal vascular structural parameters in populations with different glucose metabolism status based on color fundus photography and artificial intelligence.

Chen N, Zhu Z, Gong D, Xu X, Hu X, Yang W Front Cell Dev Biol. 2025; 13:1550176.

PMID: 39963156 PMC: 11830720. DOI: 10.3389/fcell.2025.1550176.


Deep learning model for automatic detection of different types of microaneurysms in diabetic retinopathy.

Neri G, Sharma S, Ghezzo B, Novarese C, Olivieri C, Tibaldi D Eye (Lond). 2025; 39(3):570-577.

PMID: 39789187 PMC: 11794447. DOI: 10.1038/s41433-024-03585-1.


Vulnerable parafoveal microcirculation quadrant in patients with type 2 diabetes mellitus.

Lin C, Sheen Y, Chen H, Lu Y, Chen J, Huang H Sci Rep. 2025; 15(1):1237.

PMID: 39774777 PMC: 11707366. DOI: 10.1038/s41598-024-85021-8.


Artificial intelligence-based prediction of neurocardiovascular risk score from retinal swept-source optical coherence tomography-angiography.

Germanese C, Anwer A, Eid P, Steinberg L, Guenancia C, Gabrielle P Sci Rep. 2024; 14(1):27089.

PMID: 39511360 PMC: 11544092. DOI: 10.1038/s41598-024-78587-w.


References
1.
Ogurtsova K, da Rocha Fernandes J, Huang Y, Linnenkamp U, Guariguata L, Cho N . IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128:40-50. DOI: 10.1016/j.diabres.2017.03.024. View

2.
Wong T, Cheung C, Larsen M, Sharma S, Simo R . Diabetic retinopathy. Nat Rev Dis Primers. 2016; 2:16012. DOI: 10.1038/nrdp.2016.12. View

3.
Jampol L, Glassman A, Sun J . Evaluation and Care of Patients with Diabetic Retinopathy. N Engl J Med. 2020; 382(17):1629-1637. DOI: 10.1056/NEJMra1909637. View

4.
Spaide R . Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization. Am J Ophthalmol. 2015; 160(1):6-16. DOI: 10.1016/j.ajo.2015.04.012. View

5.
Spaide R, Fujimoto J, Waheed N, Sadda S, Staurenghi G . Optical coherence tomography angiography. Prog Retin Eye Res. 2017; 64:1-55. PMC: 6404988. DOI: 10.1016/j.preteyeres.2017.11.003. View